News | May 01, 2025
Vimta Labs posts Q4 FY25 PAT at Rs. 18.31 Cr
Vimta Labs has reported total income of Rs. 96.08 crores during the period ended March 31, 2025
Vimta Labs has reported total income of Rs. 96.08 crores during the period ended March 31, 2025
Phesgo label expansion delivers on patients’ preference for at-home administration and is an important step in freeing up cancer care capacity in clinical settings
ekincare has raised a total funding of $22M since 2015 till date
The company has posted net profit of Rs. 406.7 crores for the Financial Year ended March 31, 2025
Investment demonstrates confidence in America’s commitment to science and innovation
Delivers robust earnings performance, successfully navigating a dynamic environment
The company has reported total income of Rs. 628.4 crores during the period ended March 31, 2025
Syngene reported revenue growth of 11% year-on-year, and 8% sequentially crossing the Rs. 1,000 Cr in a quarter threshold for the first time
For the financial year ended March 31, 2025, Thyrocare has reported total income of Rs.702.18 crores
Akums and TNAU will collaborate to strengthen research through shared expertise and innovative agricultural solutions, to foster innovation in formulation development
Subscribe To Our Newsletter & Stay Updated
